metallothionein has been researched along with Leukemia--Erythroblastic--Acute* in 8 studies
8 other study(ies) available for metallothionein and Leukemia--Erythroblastic--Acute
Article | Year |
---|---|
A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Friend murine erythroleukemia (MEL) cells are transformed erythroid precursors that are held in an immature and proliferating state but can be induced to differentiate in vivo by treatment with a variety of chemical agents such as N, N-hexamethylene bisacetamide (HMBA). To investigate the role of Myb proteins in maintaining MEL cells in an immature and proliferating state we have produced stable transfectants in the C19 MEL cell line that contain a dominant interfering Myb allele (MEnT) under the control of an inducible mouse metallothionein I promoter. When expression of MEnT protein was induced with ZnCl2, the stable transfectants differentiated with kinetics that were similar to wild type C19 MEL cells treated with HMBA, including induction of alpha-globin mRNA expression, assembly of hemoglobin and growth arrest. Expression of endogenous c-myb and c-myc was also decreased in response to MEnT. Expression of mad-1 mRNA was rapidly increased in response to expression of MEnT resulting in a shift from predominantly c-Myc/Max complexes to predominantly Mad/Max containing complexes. These results strongly suggest that C19 MEL cells are held in an immature and proliferating state by a pathway that is dependent on Myb activity. Topics: Acetamides; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Basic-Leucine Zipper Transcription Factors; Cell Cycle Proteins; Cell Division; DNA-Binding Proteins; Friend murine leukemia virus; Genes, myc; Globins; Hemoglobins; Leukemia, Erythroblastic, Acute; Metallothionein; Mice; Nuclear Proteins; Phosphoproteins; Plasmids; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myb; Repressor Proteins; RNA, Messenger; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Zinc | 2002 |
An upstream activator of transcription coordinately increases the level and epigenetic stability of gene expression.
The mouse metallothionein-I (mMT-I) promoter is activated by the metal response element-binding transcription factor (MTF), which binds metal response elements (MREs) when stimulated with heavy metals. We analyzed eight K562 erythroleukemia cell clones, each carrying a single integrated copy of an mMT-I/beta-geo construct, using a system that can independently assess the level of beta-geo expression and the rate at which it is silenced. In these clones, basal expression and rate of silencing vary widely and independently with integration site. This implies that the rates of transcription and of silencing are separate properties determined by interaction of the regulatory elements of the transgene with the site of integration. Induction of the mMT-I promoter with zinc both increases expression level and strongly retards silencing of beta-geo expression. At a given integration site, expression level and silencing are affected coordinately by induction. Taken together with earlier studies of distant metal-responsive elements, these results suggest that distance from the promoter may determine whether a factor can increase transcription rate. Stimulation of an MRE can both increase transcription and overcome repressive effects of chromatin; we suggest that these functions are linked. Topics: Animals; beta-Galactosidase; Cell Line; Gene Expression Regulation; Humans; Leukemia, Erythroblastic, Acute; Metallothionein; Mice; Promoter Regions, Genetic; Recombinant Proteins; Regulatory Sequences, Nucleic Acid; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Zinc | 1996 |
Chemically induced murine erythroleukemia cell differentiation is severely impaired when cAMP-dependent protein kinase activity is repressed by transfected genes.
During chemically induced differentiation of murine erythroleukemia (MEL) cells, cAMP-dependent protein kinase activity increases, and the enzyme's isozyme pattern changes. To examine the enzyme's role during MEL cell differentiation, we stably transfected MEL cells with recombinant plasmids in which the mouse metallothionein I promoter controlled expression of either a mutant form of the type I regulatory subunit of cAMP-dependent protein kinase (RI) or the enzyme's specific peptide inhibitor (PKI); expressing either sequence rendered cells cAMP-dependent protein kinase-deficient. Chemically induced differentiation of MEL cells as assessed by beta-globin mRNA and hemoglobin accumulation was inhibited in RI mutant and PKI transfectants; adding zinc further inhibited differentiation in the transfectants but had no effect on parental MEL cells. The inhibition of differentiation correlated with the amount of RI mutant mRNA and protein in the RI mutant transfectants and with the cells' degree of cAMP-dependent protein kinase deficiency in both the RI mutant and PKI transfectants. Overexpression of wild type RI did not interfere with differentiation or enzyme activity. We conclude that cAMP-dependent protein kinase activity is important for chemically induced differentiation of MEL cells and that the down-regulation of RI protein which occurs during MEL cell differentiation is not essential for differentiation to proceed. Topics: Acetamides; Animals; Blotting, Northern; Blotting, Western; Cell Differentiation; Enzyme Repression; Globins; Isoenzymes; Leukemia, Erythroblastic, Acute; Macromolecular Substances; Metallothionein; Mice; Plasmids; Promoter Regions, Genetic; Protein Kinases; RNA, Messenger; Sulfuric Acid Esters; Transfection; Tumor Cells, Cultured; Zinc | 1992 |
Increase of Cu,Zn-superoxide dismutase activity during differentiation of human K562 cells involves activation by copper of a constantly expressed copper-deficient protein.
Cu,Zn-superoxide dismutase activity, expressed on the basis of cell number, increased by 50% during sodium butyrate-induced differentiation of human K562 erythroleukemia cells. The increased enzyme activity was found to be concomitant with constant Cu,Zn-superoxide dismutase mRNA and immunoreactive protein levels and was accompanied by a rise in intracellular copper and glutathione. Incubation of K562 cell homogenates with copper caused an increase of Cu,Zn-superoxide dismutase activity which reached the levels observed after differentiation in the presence of sodium butyrate. The same treatment led to no significant activity increase in homogenates derived from differentiated cells. Externally added ceruloplasmin increased both intracellular copper levels and Cu,Zn-superoxide dismutase activity in undifferentiated cells to a level comparable with that observed after induction of differentiation. Both increments were abolished by depletion of cell glutathione. Cu,Zn-superoxide dismutase purified from control cells had both a lower kcat and a lower copper content than the enzyme purified from differentiated cells. From these data we conclude that: 1) Cu,Zn-superoxide dismutase is present in K562 cells also under the form of a less active copper-deficient enzyme, 2) the extent of enzyme activation is regulated post-translationally by differential delivery of copper as a function of differentiation stage, and 3) glutathione is likely to play a role in delivering copper to the copper-deficient protein in intact K562 cells. Topics: Catalase; Cell Differentiation; Ceruloplasmin; Chromatography, Gel; Copper; Enzyme Activation; Glutathione; Humans; Leukemia, Erythroblastic, Acute; Metallothionein; RNA, Messenger; Superoxide Dismutase; Tumor Cells, Cultured | 1991 |
Antisense RNA of the latent period gene (MER5) inhibits the differentiation of murine erythroleukemia cells.
The MER5 cDNA was cloned from RNA preferentially synthesized in murine erythroleukemia (MEL) cells during the early period of MEL cell differentiation. To understand the role of the MER5 gene in the differentiation, we have transferred the MER5 cDNA into MEL cells in both sense and antisense orientations under control of the promoter of the human metallothionein gene. Only in the transformants with the antisense MER5 cDNA, did their elevated expression inhibit differentiation. The result suggests that the MER5 gene product may promote early events in the differentiation of MEL cells. Topics: Amino Acid Sequence; Animals; Blotting, Western; Cell Differentiation; Chlorides; Cloning, Molecular; Erythrocytes; Genes; Kinetics; Leukemia, Erythroblastic, Acute; Metallothionein; Mice; Molecular Sequence Data; Promoter Regions, Genetic; RNA, Antisense; Transfection; Transformation, Genetic; Tumor Cells, Cultured; Zinc; Zinc Compounds | 1990 |
Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene.
During chemically induced differentiation of Friend virus-infected mouse erythroleukemia (MEL) cell lines, there is a biphasic down-regulation of the c-myb proto-oncogene. A plasmid containing a murine c-myb cDNA controlled by a mouse metallothionein I promoter was transfected into the C19 MEL cell line. For six transfected clones, it was found that expression of the exogenous c-myb mRNA could be up-regulated by the addition of 120 microM ZnCl2 and that the N,N'-hexamethylenebisacetamide-induced differentiation of these transfectants was inhibited in proportion to the level of exogenous c-myb mRNA expression. By adding or removing ZnCl2 at different times during the induction process, it was possible to show that up-regulation of exogenous c-myb limited to the first 2 days of induction had little or no effect on differentiation. In contrast, continuous expression of exogenous c-myb beginning at any time during the period of induction blocked further differentiation. These results suggest that during HMBA induction of MEL cells, the early down-regulation of c-myb mRNA is not necessary for terminal differentiation, whereas the down-regulation of c-myb at a later time is necessary. Topics: Animals; Cell Differentiation; Cell Line; Chlorides; Gene Expression Regulation, Neoplastic; Kinetics; Leukemia, Erythroblastic, Acute; Metallothionein; Mice; Plasmids; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myb; Proto-Oncogenes; Restriction Mapping; RNA, Neoplasm; Transfection; Zinc; Zinc Compounds | 1990 |
Probability that the commitment of murine erythroleukemia cell differentiation is determined by the c-myc level.
During the commitment of mouse erythroleukemia cell differentiation, c-myc mRNA levels change dramatically. To examine the involvement of c-myc in the commitment of these cells, we have introduced the rat c-myc gene driven by inducible, heterologous (human metallothionein IIA) gene promoter into murine erythroleukemia cells and we have examined the ability of the transformed cells to undergo commitment to terminal differentiation. The induction of the exogenous c-myc gene expression inhibited the commitment of these cells. Time-dependent inhibition of the commitment was observed with the addition of zinc at an appropriate time after the induction with dimethyl sulfoxide. The result clearly indicated that late decline, not early decline, is required for the commitment. By examining the transformants expressing the exogenous c-myc mRNA at different levels, and the induction of the exogenous c-myc mRNA by varying the concentration of zinc, we demonstrated that the commitment may be determined by a stoichiometric amount of c-myc in the defined period. The data also suggest that the probability value for the commitment process occurring in a stochastic manner is well-correlated with the amount of c-myc mRNA. Topics: Animals; Cell Differentiation; Cells, Cultured; Gene Expression Regulation; Humans; Leukemia, Erythroblastic, Acute; Metallothionein; Mice; Oncogenes; Probability; Rats; RNA, Messenger; Zinc | 1988 |
Effect of c-myc gene expression on early inducible reactions required for erythroid differentiation in vitro.
By employing cell fusion between two genetically marked mouse erythroleukemia (MEL) cells in which an artificially introduced c-myc gene had been placed under the control of human metallothionein promoter, we investigated the mechanism of the suppressive action of c-myc gene expression in erythroid differentiation. The results indicated that the expression of the c-myc gene blocked the induction of dimethyl sulfoxide-inducible activity, one of the two early activities required for triggering the differentiation. Topics: Animals; Cell Differentiation; Cell Fusion; Cell Line; Dimethyl Sulfoxide; Genes; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Metallothionein; Mice; Promoter Regions, Genetic; Proto-Oncogenes; Transcription, Genetic | 1988 |